Dyne Therapeutics Correlations

DYN Stock

USD 12.08 0.18 1.47%

The current 90-days correlation between Dyne Therapeutics and Edgewise Therapeutics is -0.26 (i.e., Very good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Dyne Therapeutics Correlation With Market

Weak diversification

The correlation between Dyne Therapeutics and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.

Moving together with Dyne Stock

0.73	EYEN	Eyenovia	Pair Corr
0.62	SNDL	SNDL Inc	Pair Corr
0.61	CLDX	Celldex Therapeutics	Pair Corr
0.63	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.82	MDAI	Spectral AI	Pair Corr
0.61	SGHT	Sight Sciences	Pair Corr

Moving against Dyne Stock

0.55	FNA	Paragon 28	Pair Corr
0.48	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.45	CMRX	Chimerix	Pair Corr
0.64	NVRO	Nevro Corp	Pair Corr
0.5	INMD	InMode	Pair Corr
0.5	LUCD	Lucid Diagnostics	Pair Corr
0.43	NYXH	Nyxoah	Pair Corr
0.76	SWZNF	Schweizerische Nationalbank	Pair Corr
0.73	TOI	Oncology Institute Earnings Call This Week	Pair Corr
0.55	GCPEF	GCL Poly Energy	Pair Corr
0.53	BRK-A	Berkshire Hathaway	Pair Corr
0.53	BRK-B	Berkshire Hathaway	Pair Corr
0.49	FWEDF	Fireweed Zinc	Pair Corr

Related Correlations Analysis

	STOK	PLRX	CYTK	RVMD	EWTX	CGEM	MLYS	DICE	KRTX	GRCL
STOK		0.7	0.45	0.74	0.48	0.73	-0.12	0.0	0.0	0.0	STOK
PLRX	0.7		0.65	0.73	0.44	0.89	-0.17	0.0	0.0	0.0	PLRX
CYTK	0.45	0.65		0.58	0.42	0.53	-0.2	0.0	0.0	0.0	CYTK
RVMD	0.74	0.73	0.58		0.29	0.83	-0.21	0.0	0.0	0.0	RVMD
EWTX	0.48	0.44	0.42	0.29		0.35	-0.23	0.0	0.0	0.0	EWTX
CGEM	0.73	0.89	0.53	0.83	0.35		0.0	0.0	0.0	0.0	CGEM
MLYS	-0.12	-0.17	-0.2	-0.21	-0.23	0.0		0.0	0.0	0.0	MLYS
DICE	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	DICE
KRTX	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	KRTX
GRCL	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		GRCL
	STOK	PLRX	CYTK	RVMD	EWTX	CGEM	MLYS	DICE	KRTX	GRCL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CGEM	+ 0.89	PLRX
CGEM	+ 0.83	RVMD
RVMD	+ 0.74	STOK
CGEM	+ 0.73	STOK
RVMD	+ 0.73	PLRX
PLRX	+ 0.7	STOK

High negative correlations

MLYS	- 0.23	EWTX
MLYS	- 0.21	RVMD
MLYS	- 0.2	CYTK
MLYS	- 0.17	PLRX
MLYS	- 0.12	STOK
GRCL	- 0.0	KRTX

Risk-Adjusted Indicators

There is a big difference between Dyne Stock performing well and Dyne Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dyne Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
STOK	3.52	(0.38)	0.00	(0.32)	0.00	0.00	7.03	(9.08)	20.29
PLRX	6.73	(1.99)	0.00	(0.60)	0.00	0.00	10.39	(14.98)	80.84
CYTK	2.26	(0.08)	0.00	(3.11)	0.00	0.00	5.41	(4.22)	17.67
RVMD	1.72	(0.14)	0.00	(0.18)	0.00	0.00	4.37	(5.89)	11.35
EWTX	2.65	(0.32)	0.00	(1.06)	0.00	0.00	4.89	(7.31)	17.09
CGEM	2.50	(0.48)	0.00	(1.13)	0.00	0.00	4.73	(6.43)	14.46
MLYS	4.46	0.68	0.17	(0.50)	4.25	(5.32)	10.04	(8.23)	50.53
DICE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
KRTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
GRCL	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Dyne Therapeutics Corporate Management

Romesh Subramanian	CoFounder Advisor	Profile
Richard MBA	Senior Administration	Profile
Ashish MBA	Chief Officer	Profile
Oxana Beskrovnaya	Chief Officer	Profile
Johanna FriedlNaderer	Chief Officer	Profile
Lucia Celona	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC